OncoMatch

OncoMatch/Clinical Trials/NCT07018869

Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors

Is NCT07018869 recruiting? Yes, currently enrolling (May 2026). This Phase 3 trial studies non-drug interventions for colorectal cancer stage ii.

Phase 3RecruitingSWOG Cancer Research NetworkNCT07018869Data as of May 2026

This phase III trial evaluates whether a web-based intervention called Current Together after Cancer (CTAC) works to increase the number of patients with surgically removed (resected) colorectal cancer who receive surveillance care that aligns with current guidelines (guideline-concordant). Surveillance care after resection of colorectal cancer is critical to detect potentially curable return of disease (recurrence), yet up to 60% of colorectal cancer survivors fail to receive surveillance. This may be due to a lack of knowledge about the purpose of surveillance care and the risks of cancer recurrence, or a lack of confidence for managing surveillance care. The CTAC intervention is an online education intervention designed to improve patients' knowledge about surveillance and their self-efficacy for managing surveillance, and to promote effective communication with supporters and supporter engagement in patients' surveillance in a way that is aligned with each patient's preferences. By increasing a patient's knowledge, self-efficacy, and satisfaction with their supporter's engagement in their care, the CTAC intervention may increase the number of patients who receive guideline-concordant surveillance care after resection of colorectal cancer.

Check if I qualify

Extracted eligibility criteria

Cancer type

Colorectal Cancer

Disease stage

Required: Stage II, III

Excluded: Stage IV

Performance status

ZUBROD 0–2

Structured fields extracted by AI. May contain errors — verify against the official protocol.

US trial sites

  • CHI Health Good Samaritan · Kearney, Nebraska
  • Alegent Health Immanuel Medical Center · Omaha, Nebraska
  • Alegent Health Bergan Mercy Medical Center · Omaha, Nebraska
  • Alegent Health Lakeside Hospital · Omaha, Nebraska
  • Creighton University Medical Center · Omaha, Nebraska

Showing up to 5 US sites. See all sites on ClinicalTrials.gov →

Could you qualify for this trial?

Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.

Check if I qualify